Sanofi Announces Licensing of Rheumatoid Arthritis Treatment

Sanofi and its specialty care global business unit, Sanofi Genzyme, have announced that the European Commission (EC) has granted marketing authorisation for Kevzara® (sarilumab) in combination with methotrexate (MTX) for the treatment of moderately-to-severely active rheumatoid arthritis (RA) in adult patients who have responded inadequately to, or who are intolerant to one or more disease [...]

By |2017-06-29T11:01:35+00:00June 29th, 2017|Industry News|Comments Off on Sanofi Announces Licensing of Rheumatoid Arthritis Treatment

First Subcutaneous C1 Esterase Inhibitor to Treat Rare Genetic Disease

The US Food and Drug Administration has approved Haegarda, the first C1 Esterase Inhibitor (Human) for subcutaneous (under the skin) administration to prevent Hereditary Angioedema (HAE) attacks in adolescent and adult patients. The subcutaneous route of administration allows for easier at-home self-injection by the patient or caregiver, once proper training is received. HAE is caused [...]

By |2017-06-29T11:00:33+00:00June 29th, 2017|Industry News|Comments Off on First Subcutaneous C1 Esterase Inhibitor to Treat Rare Genetic Disease

Action Needed to Prevent Confusion Over Medicines

Only about a third (37 per cent) of the public trust evidence from medical research, compared to approximately two-thirds (65 per cent) who trust the experiences of their friends and family, according to a recently report launched by the Academy of Medical Sciences, and part-funded by the British Heart Foundation. The new report highlights the [...]

By |2017-06-29T10:59:23+00:00June 29th, 2017|Community Pharmacy|Comments Off on Action Needed to Prevent Confusion Over Medicines

Pharmacists Impress with Penicillin Allergy Insight

A new study shows that many physicians who treat patients with ‘penicillin allergy’ listed in their charts may not fully understand important facts about penicillin allergy. They may not be aware penicillin allergy can resolve over time and they don’t fully understand the importance of allergy testing to make sure a penicillin allergy currently exists. [...]

By |2017-06-20T11:35:03+00:00June 20th, 2017|Hospital Pharmacy|Comments Off on Pharmacists Impress with Penicillin Allergy Insight

LEO Pharma Starts Phase Three Clinical Study for Tralokinumab

LEO Pharma has announced that the first patients have been dosed in a phase three clinical study of tralokinumab. Tralokinumab is an investigational human monoclonal antibody that specifically targets the cytokine IL-13, which plays an important role in the development of moderate-to-severe atopic dermatitis. Tralokinumab is not currently licensed in any indication. ECZTRA 1, the [...]

By |2017-06-20T11:34:23+00:00June 20th, 2017|Industry News|Comments Off on LEO Pharma Starts Phase Three Clinical Study for Tralokinumab

Pharmacists Urged to Participate in Know Your Numbers Week

From 18th to 24th September, charity, Blood Pressure UK, will be running its award-winning flagship campaign, Know Your Numbers! Week – the UK’s largest blood pressure testing and awareness event which encourages people to have their blood pressure measured so that they can take the steps needed to maintain a healthy blood pressure and reduce their risk [...]

By |2017-06-20T11:32:59+00:00June 20th, 2017|Community Pharmacy|Comments Off on Pharmacists Urged to Participate in Know Your Numbers Week

Aspirin Use has Limited Benefit for Patients with Hardened Arteries

For decades, aspirin has been widely used to reduce the risk of cardiovascular problems. Now, a team led by a University of Florida (UF) Health researcher has found that aspirin may provide little or no benefit for certain patients who have plaque buildup in their arteries. Aspirin is effective in treating strokes and heart attacks [...]

By |2017-06-13T10:26:25+00:00June 13th, 2017|Hospital Pharmacy|Comments Off on Aspirin Use has Limited Benefit for Patients with Hardened Arteries

Anti-Nausea Drug Could Help Treat Sleep Apnea

An old pharmaceutical product may be a new treatment for obstructive sleep apnea, according to new research presented by University of Illinois at Chicago (UIC) and Northwestern University scientists at the SLEEP 2017 annual meeting in Boston. David Carley, Professor of Biobehavioral Health Sciences, Medicine and Bioengineering at UIC; Phyllis Zee, Professor of Neurology at [...]

By |2017-06-13T10:24:29+00:00June 13th, 2017|Community Pharmacy|Comments Off on Anti-Nausea Drug Could Help Treat Sleep Apnea

Imaging Technique is a Potential Game-Changer for Pharma

In drug development, the body can be something of a black box. We take medicine and observe the overall effects, but what happens inside the body largely remains a mystery. To help clear up this picture, researchers are turning to imaging techniques in tissue and animal testing. The step has gained ground in the drug [...]

By |2017-06-13T10:03:27+00:00June 13th, 2017|Industry News|Comments Off on Imaging Technique is a Potential Game-Changer for Pharma